Interestingly, this study has shown that blocking the PD-1 by neutralizing antibodies was associated with increased IL-10 production by DCs and this did not result in a change in the immunosuppressive microenvironment of the tumour, indicating that IL-10 compensates for the PD-1 blockade. This evidence concerns the gene PDCD1 and neoplasm.